<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04712747</url>
  </required_header>
  <id_info>
    <org_study_id>MMT_2020_28</org_study_id>
    <nct_id>NCT04712747</nct_id>
  </id_info>
  <brief_title>Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)</brief_title>
  <acronym>STROKAO</acronym>
  <official_title>Adaptive Optics (AO) Analysis of Retinal Arteries in Patients With Recent Stroke (STROKAO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The eye has long been recognized as a window to pathological processes occurring in the&#xD;
      brain. By imaging the vascular system of the retina scientific understanding and clinical&#xD;
      practice have been improved for a wide range of pathologies from diabetes to stroke and&#xD;
      dementia.&#xD;
&#xD;
      Adaptive optics (AO) reveals retinal details that remain invisible with other current imaging&#xD;
      techniques. Indeed, vessels can be perfectly visualized, making it possible to detect wall&#xD;
      irregularities, accurately measure their different structures and monitor their evolution&#xD;
      under treatment if necessary.&#xD;
&#xD;
      In AO, studies on retinal vessels involve the calculation of wall thickness (WT), outer&#xD;
      diameter (OD), inner diameter (ID), wall cross-sectional area (WCSA) and wall to lumen ratio&#xD;
      (WLR). An increase in WLR &gt; 0.31 is characteristic of hypertensive microangiopathy and&#xD;
      predictive of cardiovascular and brain damage. This accurate assessment of microvascular&#xD;
      structure may even be required in the near future in all patients with arterial hypertension.&#xD;
      For vessels &gt; 300 microns in diameter, the increase in vessel wall thickness occurs without&#xD;
      changing the ID, a process known as external hypertrophic remodeling. For small arteries &lt;&#xD;
      300 microns, remodeling occurs differently. The total volume of the vessel wall remains&#xD;
      constant, but the OD and ID each decrease, a process known as inward eutrophic remodeling.&#xD;
&#xD;
      The objective of this study is to describe the parameters measured in AO in patients in the&#xD;
      acute phase of a stroke and then at 3 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2021</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Wall thickness (WT) in adaptive optics</measure>
    <time_frame>At the inclusion visit (less than 10 days after the stroke for the patients with stroke)</time_frame>
    <description>Measured in µm², Comparison between groups : hemorrhagic strokes, ischemic strokes, controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall cross-sectional area (WCSA) in adaptive optics</measure>
    <time_frame>At the inclusion visit (less than 10 days after the stroke for the patients with stroke)</time_frame>
    <description>Measured in µm², Comparison between groups : hemorrhagic strokes, ischemic strokes, controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall to lumen ratio (WLR) in adaptive optics</measure>
    <time_frame>At the inclusion visit (less than 10 days after the stroke for the patients with stroke)</time_frame>
    <description>Comparison between groups : hemorrhagic strokes, ischemic strokes, controls</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Cases - patients with stroke</arm_group_label>
    <description>Ophthalmological examinations : At the inclusion visit and 3 months after their stroke Blood pressure measurement at rest : At the inclusion visit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls - Individuals with no history of stroke</arm_group_label>
    <description>Ophthalmological examinations : At the inclusion visit Blood pressure measurement at rest : At the inclusion visit</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ophthalmological examinations</intervention_name>
    <description>OCT (Optical Coherence Tomography): posterior pole OCT B scan , optic nerve and posterior pole OCT Angiography&#xD;
Adaptive optics (AO) : Image acquisition on the vessels at the exit of the optic nerve before the first upper temporal bifurcation OD or OG and evaluation of the photoreceptor mosaic. Adaptive optics may require dilatation of the pupil with a drop of tropicamide in the eye examined a few minutes before the examination.&#xD;
Color retinophotography&#xD;
Measurement of intraocular pressure&#xD;
Patients with stroke : At the inclusion visit and 3 months after their stroke Control group : At the inclusion visit.</description>
    <arm_group_label>Cases - patients with stroke</arm_group_label>
    <arm_group_label>Controls - Individuals with no history of stroke</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood pressure measurement at rest</intervention_name>
    <description>At the inclusion visit</description>
    <arm_group_label>Cases - patients with stroke</arm_group_label>
    <arm_group_label>Controls - Individuals with no history of stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatients with confirmed stroke for less than 10 days and controls (Individuals presenting&#xD;
        at the Rothschild Foundation Hospital with no history of stroke)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  For the patients with stroke: Inpatients with confirmed stroke (clinical and imaging)&#xD;
             for less than 10 days&#xD;
&#xD;
          -  For the controls: Individuals presenting at the Rothschild Foundation Hospital with no&#xD;
             history of stroke who are matched to cases already included in the matching criteria:&#xD;
             Age ± 5 years, Gender, high blood pressure (no history, untreated, treated) Diabetes&#xD;
             (Yes, No), Body Mass Index (BMI &lt; 25, 25 ≥ BMI &lt; 30, BMI ≥ 30)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Insufficient state of consciousness or physical condition to perform the adaptive&#xD;
             optics examination&#xD;
&#xD;
          -  For the patients with stroke: Hemorrhagic post-traumatic hematoma stroke type, or&#xD;
             symptomatic stroke of a brain tumour or an arteriovenous malformation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martine MAUGET FAYSSE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Fondation A. de Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amélie YAVCHITZ, MD</last_name>
    <phone>01 48 03 64 54</phone>
    <phone_ext>+33</phone_ext>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Fondation A. de Rothschuld</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine MAUGET FAYSSE, MD</last_name>
      <phone>0148036437</phone>
      <phone_ext>+33</phone_ext>
      <email>mmfaysse@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 14, 2021</study_first_submitted>
  <study_first_submitted_qc>January 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adaptive optics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

